Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes

Podobne zapisy

• A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4(+) T cells
  od: Paas-Rozner, Miri, i wsp.
  Wydane: (2003)
• A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses
  od: Katz-Levy, Yael, i wsp.
  Wydane: (1997)
• The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes
  od: Paas-Rozner, Miri, i wsp.
  Wydane: (2001)
• Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice
  od: Paas-Rozner, Miri, i wsp.
  Wydane: (2000)
• Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4(+)CD25(+) regulatory cells
  od: Aruna, Badiga Venkata, i wsp.
  Wydane: (2005)